GlassScriptPhysician profile
Baldev K Gupta
NPI 1720168164
$5,066.64
in general payments reported to CMS, 2019-2025
39 companies · $549 in 2025
The $549 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $179 · 2021: $734 · 2022: $690 · 2023: $1,182 · 2024: $868 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,494 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,493.79 |
| Education | $105.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $514.53 | 2019-2025 | Jardiance, Trulicity |
| Teva Pharmaceuticals USA, INC. | $428.35 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $346.82 | 2021-2025 | Ingrezza |
| Astrazeneca Pharmaceuticals LP | $320.28 | 2019-2025 | Farxiga, Airsupra, Lokelma |
| Glaxosmithkline, LLC. | $317.32 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sunovion Pharmaceuticals INC. | $292.77 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $273.79 | 2019-2025 | Nuplazid |
| Pfizer INC. | $268.21 | 2019-2024 | |
| Amgen INC. | $237.30 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $218.72 | 2019-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $211.06 | 2019-2022 | |
| Abbvie INC. | $151.47 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.26 | 2019-2025 | Jardiance, Jascayd |
| Dexcom, INC. | $131.53 | 2024 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $100.99 | 2019-2023 | Eliquis |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $100.91 | 2019-2022 | |
| Exact Sciences Corporation | $89.97 | 2023-2025 | Cologuard Collection Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.62 | 2023 | Lifevest |
| Xeris Pharmaceuticals, INC. | $82.49 | 2022-2023 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $81.83 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $75.58 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $70.16 | 2023 | Aptiom |
| Biogen, INC. | $64.20 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.70 | 2025 | Caplyta |
| Lundbeck LLC | $49.51 | 2024 | Rexulti |
| Scilex Pharmaceuticals INC. | $41.86 | 2019 | |
| Phathom Pharmaceuticals, INC. | $40.29 | 2024 | Voquezna |
| Corium, LLC | $39.32 | 2023 | Adlarity |
| Urovant Sciences INC | $37.15 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $31.25 | 2022-2023 | Rexulti |
| Novo Nordisk INC | $26.02 | 2025 | Ozempic, Rybelsus |
| Tolmar, INC. | $24.30 | 2025 | Jatenzo |
| Inogen, INC. | $23.08 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Almatica Pharma LLC | $22.29 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.19 | 2024 | Nuzyra |
| Idorsia Pharmaceuticals US INC | $17.24 | 2023 | Quviviq |
| Allergan, INC. | $15.08 | 2019 | |
| Sanofi Pasteur INC. | $12.39 | 2019 | |
| Evoke Pharma, INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baldev Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.